Chloe Fenton

482 total citations
9 papers, 184 citations indexed

About

Chloe Fenton is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Immunology. According to data from OpenAlex, Chloe Fenton has authored 9 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Pharmacology and 2 papers in Immunology. Recurrent topics in Chloe Fenton's work include Adrenal Hormones and Disorders (5 papers), Hormonal Regulation and Hypertension (5 papers) and Immunotherapy and Immune Responses (2 papers). Chloe Fenton is often cited by papers focused on Adrenal Hormones and Disorders (5 papers), Hormonal Regulation and Hypertension (5 papers) and Immunotherapy and Immune Responses (2 papers). Chloe Fenton collaborates with scholars based in United Kingdom, Australia and Netherlands. Chloe Fenton's co-authors include Rowan Hardy, Gareth G. Lavery, Karim Raza, Mark S. Cooper, Ramon Langen, Justine Webster, Amy J. Naylor, Adam P. Croft, Christopher D. Buckley and Corinna Wehmeyer and has published in prestigious journals such as Science, Immunity and International Journal of Molecular Sciences.

In The Last Decade

Chloe Fenton

9 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chloe Fenton United Kingdom 8 79 43 30 30 22 9 184
Assen Goudev Bulgaria 4 25 0.3× 37 0.9× 19 0.6× 16 0.5× 12 0.5× 9 109
Keith Usiskin United States 5 149 1.9× 49 1.1× 60 2.0× 11 0.4× 30 1.4× 5 267
Funda Korkmaz United States 6 32 0.4× 45 1.0× 8 0.3× 5 0.2× 14 0.6× 12 112
Katie Sullivan Canada 8 36 0.5× 56 1.3× 33 1.1× 12 0.4× 19 0.9× 15 178
Zhiya Dong China 10 60 0.8× 123 2.9× 72 2.4× 9 0.3× 25 1.1× 39 217
Tomislav Brkić Croatia 9 16 0.2× 18 0.4× 29 1.0× 13 0.4× 14 0.6× 26 219
Albert Asante United States 7 29 0.4× 35 0.8× 37 1.2× 78 2.6× 67 3.0× 9 397
Zhen Ye China 9 33 0.4× 154 3.6× 20 0.7× 10 0.3× 8 0.4× 25 250
Han Hyuk Lim South Korea 10 61 0.8× 86 2.0× 108 3.6× 24 0.8× 38 1.7× 40 283
Maria Franaszczyk Poland 11 31 0.4× 141 3.3× 39 1.3× 16 0.5× 6 0.3× 31 360

Countries citing papers authored by Chloe Fenton

Since Specialization
Citations

This map shows the geographic impact of Chloe Fenton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Fenton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Fenton more than expected).

Fields of papers citing papers by Chloe Fenton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloe Fenton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Fenton. The network helps show where Chloe Fenton may publish in the future.

Co-authorship network of co-authors of Chloe Fenton

This figure shows the co-authorship network connecting the top 25 collaborators of Chloe Fenton. A scholar is included among the top collaborators of Chloe Fenton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe Fenton. Chloe Fenton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jobin, Katarzyna, Chloe Fenton, Anfei Huang, et al.. (2025). A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals. Science. 388(6743). eadq1405–eadq1405. 7 indexed citations
2.
Ugur, Milas, Chloe Fenton, Konrad Knöpper, et al.. (2023). Lymph node medulla regulates the spatiotemporal unfolding of resident dendritic cell networks. Immunity. 56(8). 1778–1793.e10. 20 indexed citations
3.
Fenton, Chloe, Isabella Montagna, Amy J. Naylor, et al.. (2022). 11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation. International Journal of Molecular Sciences. 23(13). 7334–7334. 7 indexed citations
4.
Webster, Justine, Chloe Fenton, Alex P. Seabright, et al.. (2021). Global Deletion of 11β-HSD1 Prevents Muscle Wasting Associated with Glucocorticoid Therapy in Polyarthritis. International Journal of Molecular Sciences. 22(15). 7828–7828. 12 indexed citations
5.
Fenton, Chloe, Adam P. Croft, Joana Campos, et al.. (2020). Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids. Annals of the Rheumatic Diseases. 80(2). 250–260. 28 indexed citations
6.
Fenton, Chloe, Craig Doig, Amy J. Naylor, et al.. (2019). 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy. Arthritis Research & Therapy. 21(1). 188–188. 32 indexed citations
7.
Fenton, Chloe, J. Matthew Webster, Corinna Wehmeyer, et al.. (2019). Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis. Arthritis Research & Therapy. 21(1). 182–182. 26 indexed citations
8.
Webster, Justine, Chloe Fenton, Ramon Langen, & Rowan Hardy. (2019). Exploring the Interface between Inflammatory and Therapeutic Glucocorticoid Induced Bone and Muscle Loss. International Journal of Molecular Sciences. 20(22). 5768–5768. 26 indexed citations
9.
Hardy, Rowan, Chloe Fenton, Adam P. Croft, et al.. (2018). 11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis. Journal of Autoimmunity. 92. 104–113. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026